Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01169467 · ClinicalTrials.gov registry record · Phase 3
Cerebral Perfusion Pressure Using Precedex and Other Sedatives
A Phase 3 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 3
- Development phase
- 89
- Enrollment target
NCT01169467 is a Phase 3 study that has completed, run by Duke University. The registered enrollment target is 89 participants.
The verdict
NCT01169467, a Phase 3 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 89 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the effects of using dexmedetomidine (Precedex) in addition to the current standard-of-care for sedation.
Interventions
- OTHER Standard-of-Care
- DRUG Standard-of-Care plus Dexmedetomidine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2009-10 |
| Est. Completion | 2013-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01169467
The ClinicalTrials.gov registry entry for NCT01169467 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 89 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard-of-Care is the first listed.
NCT01169467 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01169467 about?
NCT01169467 is a clinical study titled "Cerebral Perfusion Pressure Using Precedex and Other Sedatives". The purpose of this study is to examine the effects of using dexmedetomidine (Precedex) in addition to the current standard-of-care for sedation.
What is the current status of trial NCT01169467?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 89 participants. The study started on 2009-10. Estimated completion is 2013-11.
What interventions are being tested in trial NCT01169467?
The interventions under investigation include: Standard-of-Care (OTHER), Standard-of-Care plus Dexmedetomidine (DRUG).
Who is sponsoring clinical trial NCT01169467?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.